Recent Advances in Oncology Acupuncture and Safety Considerations in Practice
Identifieur interne : 003251 ( Pmc/Checkpoint ); précédent : 003250; suivant : 003252Recent Advances in Oncology Acupuncture and Safety Considerations in Practice
Auteurs : Weidong Lu ; Anne M. Doherty-Gilman ; David S. RosenthalSource :
- Current treatment options in oncology [ 1527-2729 ] ; 2010.
Abstract
Oncology acupuncture is a new and emerging field of research. Recent advances from published clinical trials have added evidence to support the use of acupuncture for symptom management in cancer patients. Recent new developments include (1) pain and dysfunction after neck dissection; (2) radiation-induced xerostomia in head and neck cancer; (3) aromatase inhibitor-associated arthralgia in breast cancer; (4) hot flashes in breast cancer and prostate cancer; and (5) chemotherapyinduced neutropenia in ovarian cancer. Some interventions are becoming a non-pharmaceutical option for cancer patients, while others still require further validation and confirmation. Meanwhile, owing to the rapid development of the field and increased demands from cancer patients, safety issues concerning oncology acupuncture practice have become imperative. Patients with cancer may be at higher risk developing adverse reactions from acupuncture. Practical strategies for enhancing safety measures are discussed and recommended.
Url:
DOI: 10.1007/s11864-010-0126-0
PubMed: 21103962
PubMed Central: 3148778
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:3148778Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recent Advances in Oncology Acupuncture and Safety Considerations in Practice</title><author><name sortKey="Lu, Weidong" sort="Lu, Weidong" uniqKey="Lu W" first="Weidong" last="Lu">Weidong Lu</name></author><author><name sortKey="Doherty Gilman, Anne M" sort="Doherty Gilman, Anne M" uniqKey="Doherty Gilman A" first="Anne M." last="Doherty-Gilman">Anne M. Doherty-Gilman</name></author><author><name sortKey="Rosenthal, David S" sort="Rosenthal, David S" uniqKey="Rosenthal D" first="David S." last="Rosenthal">David S. Rosenthal</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21103962</idno><idno type="pmc">3148778</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148778</idno><idno type="RBID">PMC:3148778</idno><idno type="doi">10.1007/s11864-010-0126-0</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">002793</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002793</idno><idno type="wicri:Area/Pmc/Curation">002792</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002792</idno><idno type="wicri:Area/Pmc/Checkpoint">003251</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003251</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Recent Advances in Oncology Acupuncture and Safety Considerations in Practice</title><author><name sortKey="Lu, Weidong" sort="Lu, Weidong" uniqKey="Lu W" first="Weidong" last="Lu">Weidong Lu</name></author><author><name sortKey="Doherty Gilman, Anne M" sort="Doherty Gilman, Anne M" uniqKey="Doherty Gilman A" first="Anne M." last="Doherty-Gilman">Anne M. Doherty-Gilman</name></author><author><name sortKey="Rosenthal, David S" sort="Rosenthal, David S" uniqKey="Rosenthal D" first="David S." last="Rosenthal">David S. Rosenthal</name></author></analytic><series><title level="j">Current treatment options in oncology</title><idno type="ISSN">1527-2729</idno><idno type="eISSN">1534-6277</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Opinion statement</title><p id="P2">Oncology acupuncture is a new and emerging field of research. Recent advances from published clinical trials have added evidence to support the use of acupuncture for symptom management in cancer patients. Recent new developments include (1) pain and dysfunction after neck dissection; (2) radiation-induced xerostomia in head and neck cancer; (3) aromatase inhibitor-associated arthralgia in breast cancer; (4) hot flashes in breast cancer and prostate cancer; and (5) chemotherapyinduced neutropenia in ovarian cancer. Some interventions are becoming a non-pharmaceutical option for cancer patients, while others still require further validation and confirmation. Meanwhile, owing to the rapid development of the field and increased demands from cancer patients, safety issues concerning oncology acupuncture practice have become imperative. Patients with cancer may be at higher risk developing adverse reactions from acupuncture. Practical strategies for enhancing safety measures are discussed and recommended.</p></div></front></TEI><pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">100900946</journal-id><journal-id journal-id-type="pubmed-jr-id">29659</journal-id><journal-id journal-id-type="nlm-ta">Curr Treat Options Oncol</journal-id><journal-title>Current treatment options in oncology</journal-title><issn pub-type="ppub">1527-2729</issn><issn pub-type="epub">1534-6277</issn></journal-meta><article-meta><article-id pub-id-type="pmid">21103962</article-id><article-id pub-id-type="pmc">3148778</article-id><article-id pub-id-type="doi">10.1007/s11864-010-0126-0</article-id><article-id pub-id-type="manuscript">NIHMS265202</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Recent Advances in Oncology Acupuncture and Safety Considerations in Practice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Weidong</given-names></name><degrees>MB, MPH, PhD</degrees><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Doherty-Gilman</surname><given-names>Anne M.</given-names></name><degrees>MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Rosenthal</surname><given-names>David S.</given-names></name><degrees>MD</degrees></contrib><aff id="A1">Leonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute, SW560, 44 Binney Street, Boston, MA, 02115, USA</aff></contrib-group><author-notes><corresp id="FN1"><label>*</label><email>Weidong_lu@dfci.harvard.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>24</day><month>1</month><year>2011</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>12</month><year>2011</year></pub-date><volume>11</volume><issue>3-4</issue><fpage>141</fpage><lpage>146</lpage><abstract><title>Opinion statement</title><p id="P2">Oncology acupuncture is a new and emerging field of research. Recent advances from published clinical trials have added evidence to support the use of acupuncture for symptom management in cancer patients. Recent new developments include (1) pain and dysfunction after neck dissection; (2) radiation-induced xerostomia in head and neck cancer; (3) aromatase inhibitor-associated arthralgia in breast cancer; (4) hot flashes in breast cancer and prostate cancer; and (5) chemotherapyinduced neutropenia in ovarian cancer. Some interventions are becoming a non-pharmaceutical option for cancer patients, while others still require further validation and confirmation. Meanwhile, owing to the rapid development of the field and increased demands from cancer patients, safety issues concerning oncology acupuncture practice have become imperative. Patients with cancer may be at higher risk developing adverse reactions from acupuncture. Practical strategies for enhancing safety measures are discussed and recommended.</p></abstract><contract-num rid="AT1">K01 AT004415-01
||AT</contract-num><contract-sponsor id="AT1">National Center for Complementary and Alternative Medicine : NCCAM</contract-sponsor></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Doherty Gilman, Anne M" sort="Doherty Gilman, Anne M" uniqKey="Doherty Gilman A" first="Anne M." last="Doherty-Gilman">Anne M. Doherty-Gilman</name><name sortKey="Lu, Weidong" sort="Lu, Weidong" uniqKey="Lu W" first="Weidong" last="Lu">Weidong Lu</name><name sortKey="Rosenthal, David S" sort="Rosenthal, David S" uniqKey="Rosenthal D" first="David S." last="Rosenthal">David S. Rosenthal</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003251 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 003251 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:3148778
|texte= Recent Advances in Oncology Acupuncture and Safety Considerations in Practice
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:21103962" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |